PRELUDE CAPITAL MANAGEMENT, LLC - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 33 filers reported holding CHEMBIO DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q2 2020$170,000
+16900.0%
52,252
+19996.9%
0.01%
Q1 2019$1,000
-88.9%
260
-67.5%
0.00%
-100.0%
Q2 2018$9,0008000.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,006,667$16,053,0002.62%
ARS Investment Partners, LLC 860,002$6,880,0000.84%
Gagnon Advisors, LLC 129,573$1,037,0000.77%
GAGNON SECURITIES LLC 201,698$1,614,0000.58%
PERKINS CAPITAL MANAGEMENT INC 74,500$596,0000.54%
Benchmark Capital Advisors 75,092$601,0000.48%
Cortina Asset Management, LLC 524,388$4,195,0000.21%
Whitegate Investment Counselors, Inc. 11,000$88,0000.02%
Phocas Financial Corp. 20,000$160,0000.01%
WealthTrust Fairport, LLC 14,815$119,0000.01%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders